The effect of curcuma longa on insulin resistance in PCOS patients: a randomized controlled trial

Chongqing Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) Complying with the diagnostic criteria of polycystic ovary syndrome recommended by the European Society of Human Reproductive and Embryonic Medicine (ESHRE/ASRM) in Rotterdam in 2003;
•(2) Aged 18-60 years old;
•(3) No desire for pregnancy, non-drug contraceptive measures (male using condom) were adopted after selection.

•(1) Long-term or recent exogenous androgen users or those receiving steroid corticosteroid therapy, or those receiving malignant tumors, or those who have a history of drug abuse and alcoholism in the past two years;
•(2) Those who have used metformin or other insulin sensitizers in the past month;
•(3) Complicated with other endocrine diseases, such as hyperprolactinemia, thyroid disease, androgen-secreting tumors, Cushing's syndrome, congenital adrenocortical hyperplasia and 21-hydroxylase deficiency atypical adrenocortical hyperplasia (17-hydroxyprogen level was measured).
•(4) Those with serious cardiovascular, blood, liver and kidney diseases and low immune function; those with ALT or AST higher than the upper limit of normal reference value and serum creatinine higher than the upper limit of normal reference value;
•(5) Patients who cannot take effective contraceptive measures in the course of the experiment;
•(6) Pregnant women and lactating women.

发起方

Chongqing Hospital of Traditional Chinese Medicine